ClinicalTrials.gov
ClinicalTrials.gov Menu

CT Versus CEUS Findings of Complex Cystic Renal Lesions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01159717
Recruitment Status : Completed
First Posted : July 9, 2010
Last Update Posted : July 13, 2010
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland

Brief Summary:
Retrospective comparison of complex cystic renal lesions which are found with computed tomography (CT) and were controlled with contrast enhanced ultrasound (CEUS).

Condition or disease
Kidney Neoplasms Computed Tomography Ultrasonography Contrast Media

Detailed Description:
All subjects receive an contrast enhanced CT due to different clinical indications. When a complex cystic renal lesion is found an evaluation with CEUS is performed. The CEUS protocol included a native baseline examination of both kidneys. After a bolus injection of 1.5 ml SonoVue (Bracco, Milano, Italy) an examination of the affected kidneys is performed over a time period of at least three minutes. An optional dose will be given when the initial examination is not conclusive, e. g. when the arterial phase is partly missed. When both examinations are done the lesions were classified using the Bosniak classification system and a comparison of both methods will be done.

Study Type : Observational
Actual Enrollment : 35 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Complex Cystic Renal Lesions: Evaluation of Computed Tomography Findings With Contrast Enhanced Ultrasound in Terms of the Bosniak Classification System.
Study Start Date : January 2007
Actual Primary Completion Date : December 2008
Actual Study Completion Date : July 2010




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients undergoing a CT procedure.
Criteria

Inclusion Criteria:

  • Finding of a complex cystic renal lesion

Exclusion Criteria:

  • age < 18 y, gravity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01159717


Locations
Switzerland
Department of Radiology, University Hospital Basel, University of Basel
Basel, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Principal Investigator: Joachim Hohmann, MD Department of Radiology, University Hospital Basel, University of Basel

Responsible Party: Dr. Joachim Hohmann, Department of Radiology
ClinicalTrials.gov Identifier: NCT01159717     History of Changes
Other Study ID Numbers: EK 129/09
First Posted: July 9, 2010    Key Record Dates
Last Update Posted: July 13, 2010
Last Verified: July 2010

Additional relevant MeSH terms:
Kidney Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Kidney Diseases
Urologic Diseases